HomeANIK • NASDAQ
add
Anika Therapeutics Inc
Previous close
$14.36
Day range
$13.91 - $14.67
Year range
$7.90 - $17.61
Market cap
206.51M USD
Avg Volume
157.19K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 30.62M | 0.04% |
Operating expense | 18.53M | 3.94% |
Net income | 292.00K | 101.34% |
Net profit margin | 0.95 | 101.33% |
Earnings per share | 0.31 | 1,133.33% |
EBITDA | 2.11M | 1.20% |
Effective tax rate | -135.73% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 57.48M | 3.33% |
Total assets | 190.27M | -6.15% |
Total liabilities | 46.80M | -3.99% |
Total equity | 143.46M | — |
Shares outstanding | 14.27M | — |
Price to book | 1.43 | — |
Return on assets | 0.85% | — |
Return on capital | 0.95% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 292.00K | 101.34% |
Cash from operations | 4.64M | — |
Cash from investing | 198.00K | — |
Cash from financing | -5.28M | — |
Net change in cash | -509.00K | — |
Free cash flow | 5.95M | — |
About
Founded
1983
Headquarters
Website
Employees
288
